Millions of people use over-the-counter and prescription drugs every day without experiencing serious complications; however, some individuals may experience serious or even life-threatening injuries allegedly associated with defective […]
The U.S. Food and Drug Administration (FDA) is requesting that all manufacturers immediately withdraw prescription and over-the-counter forms of Zantac from the market after new evidence reportedly shows […]
As a result of the consolidation of approximately 140 Zantac lawsuits, plaintiffs and defendants have submitted a proposal that would allow direct filing of lawsuits in the Southern […]
On October 1, 2019, Johnson & Johnson announced it had reached a $20.4 million settlement with two counties in Ohio as part of the ongoing opioid crisis in […]
Pharmacies and other major retailers across the United States have reportedly started pulling generic versions of Zantac from their shelves after the U.S. Food and Drug Administration (FDA) […]
Attorneys are looking into reports related to the aggressive promotion and marketing of prescription medication Nuedexta. According to an investigation by CNN, pharmaceutical sales representatives affiliated with the […]
A jury has awarded $15 million to the family of a 10-year-old boy who allegedly developed spina bifida after his mother took Depakote to treat her bipolar disorder […]
A Nexium lawyer notes a lawsuit in which the plaintiff claims to have been diagnosed with chronic kidney disease after using the medication regularly for almost 10 years. Since […]
A generic drug antitrust lawsuit may be an option for individuals and other parties who purchased certain generic drugs on at least one occasion after June 1, 2013. […]
An Abilify injury attorney notes that a $19.5 million multistate settlement has been reached with Bristol-Myers Squibb after the drug maker allegedly used improper promotional practices to market the medication. As […]
An Actos bladder cancer lawyer notes that the U.S. Food and Drug Administration (FDA) has concluded that the use of type 2 diabetes medications containing pioglitazone, including Actos, may […]
An Onglyza injury attorney notes that the U.S. Food and Drug Administration (FDA) is reportedly revising the warning label of the diabetes medication Onglyza to reflect the potential […]
An HPV vaccine attorney notes that the American College of Pediatricians has issued a warning against a recommended human papillomavirus infection (HPV) vaccine due to a possible association […]
A Xarelto bleeding injury attorney notes that the first bellwether trials involving patients who claim they were harmed by the drug may begin in summer 2017. Lawsuits allege […]
An Onglyza heart failure lawyer notes that existing research indicates a possible increased risk of heart failure among patients using Onglyza. As a result, the U.S. Food and […]